Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

Ruth Wester; Sonja Zweegman; Bronno van der Holt; Marie José Kersten; Edo Vellenga; Marinus van Marwijk-Kooy; Emelie Asselbergs; Okke de Weerdt; Monique C Minnema; Sarah Lonergan; Antonio Palumbo; Annemiek Broijl; Pieter Sonneveld

doi:10.1097/HS9.0000000000000370

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

Ruth Wester^*, Sonja Zweegman, Bronno van der Holt, Marie José Kersten, Edo Vellenga, Marinus van Marwijk-Kooy, Emelie Asselbergs, Okke de Weerdt, Monique C Minnema, Sarah Lonergan, Antonio Palumbo, Annemiek Broijl, Pieter Sonneveld

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput › Academic › peer review

55 Downloads (Pure)

Originele taal-2	English
Artikelnummer	e370
Aantal pagina's	3
Tijdschrift	HemaSphere
Volume	4
Nummer van het tijdschrift	4
DOI's	https://doi.org/10.1097/HS9.0000000000000370
Status	Published - aug.-2020

Toegang tot document

10.1097/HS9.0000000000000370Licentie: CC BY-NC-ND

Carfilzomib_Combined_With_Thalidomide_and_Low_dose.19Final publisher's version, 422 KBLicentie: CC BY-NC-ND

Handle.net

Permanente koppeling

Citeer dit

Wester, R., Zweegman, S., van der Holt, B., Kersten, M. J., Vellenga, E., van Marwijk-Kooy, M., Asselbergs, E., de Weerdt, O., Minnema, M. C., Lonergan, S., Palumbo, A., Broijl, A., & Sonneveld, P. (2020). Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial. HemaSphere, 4(4), [e370]. https://doi.org/10.1097/HS9.0000000000000370

@article{23d49c27aadf474fa61d6bcc11d24bf7,

title = "Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial",

author = "Ruth Wester and Sonja Zweegman and {van der Holt}, Bronno and Kersten, {Marie Jos{\'e}} and Edo Vellenga and {van Marwijk-Kooy}, Marinus and Emelie Asselbergs and {de Weerdt}, Okke and Minnema, {Monique C} and Sarah Lonergan and Antonio Palumbo and Annemiek Broijl and Pieter Sonneveld",

year = "2020",

month = aug,

doi = "10.1097/HS9.0000000000000370",

language = "English",

volume = "4",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "4",

}

Wester, R, Zweegman, S, van der Holt, B, Kersten, MJ, Vellenga, E, van Marwijk-Kooy, M, Asselbergs, E, de Weerdt, O, Minnema, MC, Lonergan, S, Palumbo, A, Broijl, A & Sonneveld, P 2020, 'Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial', HemaSphere, vol. 4, nr. 4, e370. https://doi.org/10.1097/HS9.0000000000000370

Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma : 8 vs 4 Induction Cycles; the Carthadex Trial. / Wester, Ruth; Zweegman, Sonja; van der Holt, Bronno et al.

In: HemaSphere, Vol. 4, Nr. 4, e370, 08.2020.

Onderzoeksoutput › Academic › peer review

TY - JOUR

T1 - Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma

T2 - 8 vs 4 Induction Cycles; the Carthadex Trial

AU - Wester, Ruth

AU - Zweegman, Sonja

AU - van der Holt, Bronno

AU - Kersten, Marie José

AU - Vellenga, Edo

AU - van Marwijk-Kooy, Marinus

AU - Asselbergs, Emelie

AU - de Weerdt, Okke

AU - Minnema, Monique C

AU - Lonergan, Sarah

AU - Palumbo, Antonio

AU - Broijl, Annemiek

AU - Sonneveld, Pieter

PY - 2020/8

Y1 - 2020/8

U2 - 10.1097/HS9.0000000000000370

DO - 10.1097/HS9.0000000000000370

M3 - Letter

C2 - 32885140

SN - 2572-9241

VL - 4

JO - HemaSphere

JF - HemaSphere

IS - 4

M1 - e370

ER -

Wester R, Zweegman S, van der Holt B, Kersten MJ, Vellenga E, van Marwijk-Kooy M et al. Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial. HemaSphere. 2020 aug.;4(4):e370. doi: 10.1097/HS9.0000000000000370